Review
Jul 2026
Biomimetic Nanoparticles for Metastatic Breast Cancer: Advancing Targeted Drug Delivery Beyond Conventional Nanomedicine.
In preclinical studies, BMNPs often show enhanced tumor accumulation, prolonged circulation, and reduced systemic toxicity compared with uncoated nanoparticles, although reporting heterogeneity limits direct comparisons.
Urushi Rehman, Tenzin Sonam Dongsar, Tenzin Tsering Dongsar et al.
· Critical reviews in oncology... · 0 citations